Skip to main content
Company
Overview
Management
Supervisory Board
Research & Development
Portfolio overview
ADC technology
ADC Projects
Expanded Access Policy
Out-licensed product candidates
Funded projects
Publications
Scientific posters
Partnering
Press & Investors
Strategy and Facts
Strategy
Facts
Shareholder information
Share, Shareholder Structure, Basic Information
Financing History
Analysts
Capital Increase
Announcements
Press Releases and Ad-hoc Announcements
Financial Reports
Voting Rights
Directors' Dealings
Calendar and Presentations
Conferences & Presentations
Financial Calendar
Annual General Meeting
Corporate Governance
Corporate Bodies and Shareholdings
Statement on Corporate Governance
Declaration of Conformity
Articles of Association
Rules of Procedure of the Supervisory Board
Remuneration system of the Management Board and Supervisory Board
Remuneration Reports
Compliance
Code of Conduct
Whistleblower system
Newsletter subscription
Career
Overview
Job offers
Application process
Contact
Imprint
Privacy Policy
Disclaimer
Supplier & partners
Contact
English
Deutsch
Company
Overview
Management
Supervisory Board
Research & Development
Portfolio overview
ADC technology
ADC Projects
Expanded Access Policy
Out-licensed product candidates
Funded projects
Publications
Scientific posters
Partnering
Press & Investors
Strategy and Facts
Strategy
Facts
Shareholder information
Share, Shareholder Structure, Basic Information
Financing History
Analysts
Capital Increase
Announcements
Press Releases and Ad-hoc Announcements
Financial Reports
Voting Rights
Directors' Dealings
Calendar and Presentations
Conferences & Presentations
Financial Calendar
Annual General Meeting
Corporate Governance
Corporate Bodies and Shareholdings
Statement on Corporate Governance
Declaration of Conformity
Articles of Association
Rules of Procedure of the Supervisory Board
Remuneration system of the Management Board and Supervisory Board
Remuneration Reports
Compliance
Code of Conduct
Whistleblower system
Newsletter subscription
Career
Overview
Job offers
Application process
Show all
2026
2025
2024
2023
2022
Presse- & Adhoc-Mitteilungen
16 December 2022
PM: Heidelberg Pharma unterzeichnet Forschungs- und exklusive Optionsvereinbarung mit der Binghamton University über immunstimulierende Technologieplattform
PDF
10 November 2022
PM: Heidelberg Pharma und Partner Magenta präsentieren auf der ASH-Jahrestagung 2022 erste klinische Daten zu ihren Antikörper-Wirkstoff-Konjugaten
PDF
07 November 2022
PM: Heidelberg Pharma Partner Telix berichtet positive Daten der ZIRCON-Zulassungsstudie
PDF
13 October 2022
PM: Heidelberg Pharma AG: Zwischenmitteilung für die ersten neun Monate 2022
PDF
04 October 2022
AH: Heidelberg Pharma AG gibt Änderung der Prognose bekannt
PDF
09 September 2022
AH: Heidelberg Pharma schließt Lizenzvereinbarung mit Partner Takeda zur Entwicklung eines Antikörper-Amanitin-Konjugats ab
PDF
